Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a smartphone app ease the burden on young carers?

NCT ID NCT03824210

Symptom relief Sponsor: East and North Hertfordshire NHS Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study works with young carers aged 11 to 18 to co-create and test a mobile phone app and booklet. The goal is to help them find information, connect with local support, and better manage their caring role. Researchers will gather feedback and track app usage to see if it truly helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a mobile phone app co-produced with young carers
What this could lead to
If successful, this app could provide a scalable, low-cost way to improve well-being and access to support for young carers.
What could go wrong
This is a small pilot study with only 50 participants, so results may not apply to all young carers. The app's impact depends on sustained engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

50 people

The number who actually took part.

Started

Mar 2019

Finished

Dec 2020

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Young Carers in Hertfordshire

Ages

11 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * School children from nominated schools in Hertfordshire (stage 1) * Ability to provide informed consent (consent processes/literature will be age appropriate 11-17) (stage 2) * Able to complete questionnaires (stage 2) Exclusion Criteria: * Does not speak or understand English * Lacks mental capacity * Young carers outside Hertfordshire

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARING

Contacts and locations

Locations

  • East and North Hertfordshire NHS Trust

    Stevenage, SG14AB, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.